New Antibody-Drug conjugate 3H-10000 enters human trials for Hard-to-Treat cancers
Disease control
Recruiting now
This study tests a new drug called 3H-10000, which is an antibody-drug conjugate designed to target and kill cancer cells. It is for people with advanced lung or stomach cancer that cannot be removed by surgery or has spread. The trial will enroll 170 participants to find the saf…
Phase: PHASE1, PHASE2 • Sponsor: 3H Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 24, 2026 03:01 UTC